No connection

Search Results

LPCN vs OSRH

LPCN
Lipocine Inc.
BEARISH
Price
$2.38
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%
OSRH
OSR Holdings, Inc.
BEARISH
Price
$0.55
Market Cap
$18.1M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
LPCN
--
OSRH
--
Forward P/E
LPCN
-1.92
OSRH
--
P/B Ratio
LPCN
1.01
OSRH
0.19
P/S Ratio
LPCN
8.79
OSRH
6.23
EV/EBITDA
LPCN
-0.29
OSRH
-7.78

Profitability

Gross Margin
LPCN
100.0%
OSRH
19.14%
Operating Margin
LPCN
-219.65%
OSRH
-1674.81%
Profit Margin
LPCN
0.0%
OSRH
0.0%
ROE
LPCN
-54.28%
OSRH
-20.03%
ROA
LPCN
-32.81%
OSRH
-6.62%

Growth

Revenue Growth
LPCN
-67.2%
OSRH
-58.3%
Earnings Growth
LPCN
--
OSRH
--

Financial Health

Debt/Equity
LPCN
0.03
OSRH
0.03
Current Ratio
LPCN
6.68
OSRH
0.16
Quick Ratio
LPCN
6.36
OSRH
0.12

Dividends

Dividend Yield
LPCN
--
OSRH
--
Payout Ratio
LPCN
0.0%
OSRH
0.0%

AI Verdict

LPCN BEARISH

LPCN exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration across all financial health dimensions. While the company maintains a strong liquidity position with a current ratio of 6.68 and negligible debt, these are offset by a catastrophic 67.2% year-over-year revenue collapse and an operating margin of -219.65%. The technical trend is entirely bearish (0/100), and the stock has lost over 90% of its value over five years. Despite a lone analyst's optimistic $11.00 target, the data suggests a company in operational distress.

Strengths
Very low debt-to-equity ratio (0.03)
Strong short-term liquidity (Current Ratio 6.68)
Trading near book value (P/B 1.01)
Risks
Severe revenue decline (-67.2% YoY)
Critical financial health score (Piotroski 0/9)
Extreme negative operating margins (-219.65%)
OSRH BEARISH

OSRH exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic Current Ratio of 0.16, indicating an inability to meet short-term obligations. The company is experiencing a collapse in top-line growth with revenue declining 58.30% YoY, coupled with an unsustainable operating margin of -1674.81%. While the Price-to-Book ratio of 0.19 suggests deep value, the lack of liquidity and negative earnings trajectory point toward a high risk of insolvency. The single analyst target of $10.00 is completely decoupled from the current fundamental reality.

Strengths
Very low Debt/Equity ratio (0.03)
Trading significantly below book value (P/B 0.19)
Recent short-term price momentum (1-month +21.5%)
Risks
Severe liquidity crisis (Current Ratio 0.16)
Rapidly declining revenue (-58.30% YoY)
Extreme operational inefficiency (Operating Margin -1674.81%)

Compare Another Pair

LPCN vs OSRH: Head-to-Head Comparison

This page compares Lipocine Inc. (LPCN) and OSR Holdings, Inc. (OSRH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile